122 related articles for article (PubMed ID: 16168958)
1. Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1.
Malerød L; Sporstøl M; Juvet LK; Mousavi SA; Gjøen T; Berg T; Roos N; Eskild W
Biochem Biophys Res Commun; 2005 Nov; 336(4):1096-105. PubMed ID: 16168958
[TBL] [Abstract][Full Text] [Related]
2. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
[TBL] [Abstract][Full Text] [Related]
3. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.
Neimark E; Chen F; Li X; Shneider BL
Hepatology; 2004 Jul; 40(1):149-56. PubMed ID: 15239098
[TBL] [Abstract][Full Text] [Related]
4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
5. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
[TBL] [Abstract][Full Text] [Related]
6. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
7. The role of cyclic AMP response element binding protein in transactivation of scavenger receptor class B type I promoter in transfected cells and in primary cultures of rat theca-interstitial cells.
Towns R; Menon KM
Mol Cell Endocrinol; 2005 Dec; 245(1-2):23-30. PubMed ID: 16298471
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms.
Cai SY; He H; Nguyen T; Mennone A; Boyer JL
J Lipid Res; 2010 Aug; 51(8):2265-74. PubMed ID: 20338915
[TBL] [Abstract][Full Text] [Related]
9. Activation of the rat scavenger receptor class B type I gene by PPARalpha.
Lopez D; McLean MP
Mol Cell Endocrinol; 2006 Jun; 251(1-2):67-77. PubMed ID: 16584836
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human liver delta-aminolevulinic acid synthase by bile acids.
Peyer AK; Jung D; Beer M; Gnerre C; Keogh A; Stroka D; Zavolan M; Meyer UA
Hepatology; 2007 Dec; 46(6):1960-70. PubMed ID: 17975826
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia suppresses hepatic scavenger receptor class B type I expression.
Murao K; Yu X; Imachi H; Cao WM; Chen K; Matsumoto K; Nishiuchi T; Wong NC; Ishida T
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E78-87. PubMed ID: 17957039
[TBL] [Abstract][Full Text] [Related]
12. Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver.
Trottier J; Verreault M; Grepper S; Monté D; Bélanger J; Kaeding J; Caron P; Inaba TT; Barbier O
Hepatology; 2006 Nov; 44(5):1158-70. PubMed ID: 17058234
[TBL] [Abstract][Full Text] [Related]
13. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
[TBL] [Abstract][Full Text] [Related]
14. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.
Goodwin B; Jones SA; Price RR; Watson MA; McKee DD; Moore LB; Galardi C; Wilson JG; Lewis MC; Roth ME; Maloney PR; Willson TM; Kliewer SA
Mol Cell; 2000 Sep; 6(3):517-26. PubMed ID: 11030332
[TBL] [Abstract][Full Text] [Related]
15. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
[TBL] [Abstract][Full Text] [Related]
16. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
Song KH; Li T; Owsley E; Strom S; Chiang JY
Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
[TBL] [Abstract][Full Text] [Related]
17. Regulation of SR-BI protein levels by phosphorylation of its associated protein, PDZK1.
Nakamura T; Shibata N; Nishimoto-Shibata T; Feng D; Ikemoto M; Motojima K; Iso-O N; Tsukamoto K; Tsujimoto M; Arai H
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13404-9. PubMed ID: 16174736
[TBL] [Abstract][Full Text] [Related]
18. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes.
Malerød L; Juvet LK; Hanssen-Bauer A; Eskild W; Berg T
Biochem Biophys Res Commun; 2002 Dec; 299(5):916-23. PubMed ID: 12470667
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
[TBL] [Abstract][Full Text] [Related]
20. Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in rat hepatocytes.
Monte MJ; Rosales R; Macias RI; Iannota V; Martinez-Fernandez A; Romero MR; Hofmann AF; Marin JJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G54-G62. PubMed ID: 18467501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]